Permira Seeks $4 Billion For Sale Of Contract Drugmaker Cambrex- FT
ReutersSep 6, 2025 11:52 AM
Sept 6 (Reuters) -
PERMIRA SEEKS $4BN FOR SALE OF CONTRACT DRUGMAKER CAMBREX-FT
Source text: https://tinyurl.com/eaxxtpjb
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Apple’s Big September Moment Is Almost Here — What’s Priced In?
TradingKey - Apple (AAPL) has staged a strong rebound lately, with shares up 14% in August as investors breathed a sigh of relief over easing tariff risks. But whether the rally can keep going may depend on one thing: next week’s product launch.TradingKey
2 hours ago
Japan Q2 GDP Commentary: Growth Revised Upward, Yen May Rise
TradingKey - On 8 September 2025, Japan released the revised Q2 GDP figures. The data showed that real GDP grew by 0.5% quarter-on-quarter, surpassing market expectations of 0.3% and the previous quarter’s 0% growth.TradingKey
20 hours ago
U.S. August Nonfarm Payroll Preview: Risks Focus on Downward Revision of July Data
TradingKey - On 5 September 2025, the U.S. Department of Labour will release the August Non-Farm Payrolls report. The market widely expects August to see an addition of 75,000 non-farm jobs, roughly in line with July’s 73,000.TradingKey
Thu, Sep 4
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Tradingkey
